Compile Data Set for Download or QSAR
Report error Found 322 Enz. Inhib. hit(s) with all data for entry = 13404
TargetHistone deacetylase 6(Human)
Tenaya Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 787492BDBM787492(US20250346922, Compound II-8B)
Affinity DataIC50: 0.275nMAssay Description:The compounds disclosed herein, in particular those of Formula (II), were synthesized according to methods disclosed in WO 2021/067859, which is inco...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
3/5/2026
Entry Details
US Patent

TargetHistone deacetylase 6(Human)
Tenaya Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 50557845BDBM50557845(CHEMBL4756236 | WO2021067859, Compound I-9A | US20...)
Affinity DataIC50: 0.351nMAssay Description:The compounds disclosed herein, in particular those of Formula (II), were synthesized according to methods disclosed in WO 2021/067859, which is inco...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/5/2026
Entry Details
US Patent

TargetHistone deacetylase 6(Human)
Tenaya Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 50557847BDBM50557847(CHEMBL4749714 | WO2021067859, Compound I-19 | US20...)
Affinity DataIC50: 0.425nMAssay Description:The compounds disclosed herein, in particular those of Formula (II), were synthesized according to methods disclosed in WO 2021/067859, which is inco...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/5/2026
Entry Details
US Patent

TargetHistone deacetylase 6(Human)
Tenaya Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 50557849BDBM50557849(CHEMBL4751524 | WO2021067859, Compound IV-9 | US20...)
Affinity DataIC50: 0.595nMAssay Description:The compounds disclosed herein, in particular those of Formula (II), were synthesized according to methods disclosed in WO 2021/067859, which is inco...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/5/2026
Entry Details
US Patent

TargetHistone deacetylase 6(Human)
Tenaya Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 50557848BDBM50557848(CHEMBL4777764 | WO2021067859, Compound I-21 | US20...)
Affinity DataIC50: 0.601nMAssay Description:The compounds disclosed herein, in particular those of Formula (II), were synthesized according to methods disclosed in WO 2021/067859, which is inco...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/5/2026
Entry Details
US Patent

TargetHistone deacetylase 6(Human)
Tenaya Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 50557846BDBM50557846(CHEMBL4762877 | US20250346922, Compound II-11)
Affinity DataIC50: 0.639nMAssay Description:The compounds disclosed herein, in particular those of Formula (II), were synthesized according to methods disclosed in WO 2021/067859, which is inco...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/5/2026
Entry Details
US Patent

TargetHistone deacetylase 6(Human)
Tenaya Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 637073BDBM637073(WO2021067859, Compound I-25 | US20250346922, Compo...)
Affinity DataIC50: 0.669nMAssay Description:The compounds disclosed herein, in particular those of Formula (II), were synthesized according to methods disclosed in WO 2021/067859, which is inco...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
3/5/2026
Entry Details
US Patent

TargetHistone deacetylase 6(Human)
Tenaya Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 787485BDBM787485(US20250346922, Compound III-2)
Affinity DataIC50: 0.677nMAssay Description:The compounds disclosed herein, in particular those of Formula (II), were synthesized according to methods disclosed in WO 2021/067859, which is inco...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
3/5/2026
Entry Details
US Patent

TargetHistone deacetylase 6(Human)
Tenaya Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 637063BDBM637063(WO2021067859, Compound I-9B | US20250346922, Compo...)
Affinity DataIC50: 0.791nMAssay Description:The compounds disclosed herein, in particular those of Formula (II), were synthesized according to methods disclosed in WO 2021/067859, which is inco...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
3/5/2026
Entry Details
US Patent

TargetHistone deacetylase 6(Human)
Tenaya Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 637080BDBM637080(WO2021067859, Compound I-12B | US20250346922, Comp...)
Affinity DataIC50: 0.809nMAssay Description:The compounds disclosed herein, in particular those of Formula (II), were synthesized according to methods disclosed in WO 2021/067859, which is inco...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/5/2026
Entry Details
US Patent

TargetHistone deacetylase 6(Human)
Tenaya Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 787506BDBM787506(US20250346922, Compound III-7)
Affinity DataIC50: 1.10nMAssay Description:The compounds disclosed herein, in particular those of Formula (II), were synthesized according to methods disclosed in WO 2021/067859, which is inco...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
3/5/2026
Entry Details
US Patent

TargetHistone deacetylase 6(Human)
Tenaya Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 637071BDBM637071(WO2021067859, Compound I-17 | US20250346922, Compo...)
Affinity DataIC50: 1.12nMAssay Description:The compounds disclosed herein, in particular those of Formula (II), were synthesized according to methods disclosed in WO 2021/067859, which is inco...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/5/2026
Entry Details
US Patent

TargetHistone deacetylase 6(Human)
Tenaya Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 637092BDBM637092(WO2021067859, Compound I-27 | US20250346922, Compo...)
Affinity DataIC50: 1.13nMAssay Description:The compounds disclosed herein, in particular those of Formula (II), were synthesized according to methods disclosed in WO 2021/067859, which is inco...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/5/2026
Entry Details
US Patent

TargetHistone deacetylase 6(Human)
Tenaya Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 637072BDBM637072(WO2021067859, Compound 4 | US20250346922, Compound...)
Affinity DataIC50: 1.20nMAssay Description:The compounds disclosed herein, in particular those of Formula (II), were synthesized according to methods disclosed in WO 2021/067859, which is inco...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/5/2026
Entry Details
US Patent

TargetHistone deacetylase 6(Human)
Tenaya Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 787519BDBM787519(US20250346922, Compound II-30A)
Affinity DataIC50: 1.36nMAssay Description:The compounds disclosed herein, in particular those of Formula (II), were synthesized according to methods disclosed in WO 2021/067859, which is inco...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
3/5/2026
Entry Details
US Patent

TargetHistone deacetylase 6(Human)
Tenaya Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 637088BDBM637088(WO2021067859, Compound 5 | US20250346922, Compound...)
Affinity DataIC50: 1.49nMAssay Description:The compounds disclosed herein, in particular those of Formula (II), were synthesized according to methods disclosed in WO 2021/067859, which is inco...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/5/2026
Entry Details
US Patent

TargetHistone deacetylase 6(Human)
Tenaya Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 637053BDBM637053(WO2021067859, Compound I-7A | US20250346922, Compo...)
Affinity DataIC50: 1.5nMAssay Description:The compounds disclosed herein, in particular those of Formula (II), were synthesized according to methods disclosed in WO 2021/067859, which is inco...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/5/2026
Entry Details
US Patent

TargetHistone deacetylase 6(Human)
Tenaya Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 637077BDBM637077(WO2021067859, Compound I-23 | US20250346922, Compo...)
Affinity DataIC50: 1.59nMAssay Description:The compounds disclosed herein, in particular those of Formula (II), were synthesized according to methods disclosed in WO 2021/067859, which is inco...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/5/2026
Entry Details
US Patent

TargetHistone deacetylase 6(Human)
Tenaya Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 637049BDBM637049(WO2021067859, Compound I-6 | US20250346922, Compou...)
Affinity DataIC50: 1.61nMAssay Description:The compounds disclosed herein, in particular those of Formula (II), were synthesized according to methods disclosed in WO 2021/067859, which is inco...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/5/2026
Entry Details
US Patent

TargetHistone deacetylase 6(Human)
Tenaya Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 637067BDBM637067(WO2021067859, Compound I-16 | US20250346922, Compo...)
Affinity DataIC50: 1.61nMAssay Description:The compounds disclosed herein, in particular those of Formula (II), were synthesized according to methods disclosed in WO 2021/067859, which is inco...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/5/2026
Entry Details
US Patent

TargetHistone deacetylase 6(Human)
Tenaya Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 637087BDBM637087(WO2021067859, Compound I-8A | US20250346922, Compo...)
Affinity DataIC50: 1.65nMAssay Description:The compounds disclosed herein, in particular those of Formula (II), were synthesized according to methods disclosed in WO 2021/067859, which is inco...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/5/2026
Entry Details
US Patent

TargetHistone deacetylase 6(Human)
Tenaya Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 637066BDBM637066(WO2021067859, Compound I-18 | WO2021067859, Compou...)
Affinity DataIC50: 1.68nMAssay Description:The compounds disclosed herein, in particular those of Formula (II), were synthesized according to methods disclosed in WO 2021/067859, which is inco...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/5/2026
Entry Details
US Patent

TargetHistone deacetylase 6(Human)
Tenaya Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 637078BDBM637078(WO2021067859, Compound III-1 | US20250346922, Comp...)
Affinity DataIC50: 1.79nMAssay Description:The compounds disclosed herein, in particular those of Formula (II), were synthesized according to methods disclosed in WO 2021/067859, which is inco...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/5/2026
Entry Details
US Patent

TargetHistone deacetylase 6(Human)
Tenaya Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 637059BDBM637059(WO2021067859, Compound IV-4 | US20250346922, Compo...)
Affinity DataIC50: 1.80nMAssay Description:The compounds disclosed herein, in particular those of Formula (II), were synthesized according to methods disclosed in WO 2021/067859, which is inco...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/5/2026
Entry Details
US Patent

TargetHistone deacetylase 6(Human)
Tenaya Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 787517BDBM787517(US20250346922, Compound II-28A)
Affinity DataIC50: 1.81nMAssay Description:The compounds disclosed herein, in particular those of Formula (II), were synthesized according to methods disclosed in WO 2021/067859, which is inco...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
3/5/2026
Entry Details
US Patent

TargetHistone deacetylase 6(Human)
Tenaya Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 637079BDBM637079(WO2021067859, Compound IV-5 | US20250346922, Compo...)
Affinity DataIC50: 2.04nMAssay Description:The compounds disclosed herein, in particular those of Formula (II), were synthesized according to methods disclosed in WO 2021/067859, which is inco...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/5/2026
Entry Details
US Patent

TargetHistone deacetylase 6(Human)
Tenaya Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 787514BDBM787514(US20250346922, Compound II-26B)
Affinity DataIC50: 2.23nMAssay Description:The compounds disclosed herein, in particular those of Formula (II), were synthesized according to methods disclosed in WO 2021/067859, which is inco...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
3/5/2026
Entry Details
US Patent

TargetHistone deacetylase 6(Human)
Tenaya Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 787505BDBM787505(US20250346922, Compound III-10)
Affinity DataIC50: 2.30nMAssay Description:The compounds disclosed herein, in particular those of Formula (II), were synthesized according to methods disclosed in WO 2021/067859, which is inco...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
3/5/2026
Entry Details
US Patent

TargetHistone deacetylase 6(Human)
Tenaya Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 637100BDBM637100(WO2021067859, Compound I-34 | US20250346922, Compo...)
Affinity DataIC50: 2.32nMAssay Description:The compounds disclosed herein, in particular those of Formula (II), were synthesized according to methods disclosed in WO 2021/067859, which is inco...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/5/2026
Entry Details
US Patent

TargetHistone deacetylase 6(Human)
Tenaya Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 593464BDBM593464(US11578066, Compound I-156 | N-(5-chloropyridin-3-...)
Affinity DataIC50: 2.53nMAssay Description:The compounds disclosed herein, in particular those of Formula (II), were synthesized according to methods disclosed in WO 2021/067859, which is inco...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/5/2026
Entry Details
US Patent

TargetHistone deacetylase 6(Human)
Tenaya Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 637091BDBM637091(WO2021067859, Compound 6 | US20250346922, Compound...)
Affinity DataIC50: 2.54nMAssay Description:The compounds disclosed herein, in particular those of Formula (II), were synthesized according to methods disclosed in WO 2021/067859, which is inco...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/5/2026
Entry Details
US Patent

TargetHistone deacetylase 6(Human)
Tenaya Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 637085BDBM637085(WO2021067859, Compound I-15 | US20250346922, Compo...)
Affinity DataIC50: 2.64nMAssay Description:The compounds disclosed herein, in particular those of Formula (II), were synthesized according to methods disclosed in WO 2021/067859, which is inco...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/5/2026
Entry Details
US Patent

TargetHistone deacetylase 6(Human)
Tenaya Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 637062BDBM637062(WO2021067859, Compound IV-3 | US20250346922, Compo...)
Affinity DataIC50: 3.35nMAssay Description:The compounds disclosed herein, in particular those of Formula (II), were synthesized according to methods disclosed in WO 2021/067859, which is inco...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/5/2026
Entry Details
US Patent

TargetHistone deacetylase 6(Human)
Tenaya Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 637076BDBM637076(WO2021067859, Compound I-22 | US20250346922, Compo...)
Affinity DataIC50: 3.36nMAssay Description:The compounds disclosed herein, in particular those of Formula (II), were synthesized according to methods disclosed in WO 2021/067859, which is inco...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/5/2026
Entry Details
US Patent

TargetHistone deacetylase 6(Human)
Tenaya Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 787510BDBM787510(US20250346922, Compound II-20)
Affinity DataIC50: 3.78nMAssay Description:The compounds disclosed herein, in particular those of Formula (II), were synthesized according to methods disclosed in WO 2021/067859, which is inco...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
3/5/2026
Entry Details
US Patent

TargetHistone deacetylase 6(Human)
Tenaya Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 593418BDBM593418(US11578066, Compound I-109 | N-(5-chloropyridin-3-...)
Affinity DataIC50: 3.92nMAssay Description:The compounds disclosed herein, in particular those of Formula (II), were synthesized according to methods disclosed in WO 2021/067859, which is inco...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/5/2026
Entry Details
US Patent

TargetHistone deacetylase 6(Human)
Tenaya Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 637083BDBM637083(WO2021067859, Compound IV-6 | US20250346922, Compo...)
Affinity DataIC50: 4.06nMAssay Description:The compounds disclosed herein, in particular those of Formula (II), were synthesized according to methods disclosed in WO 2021/067859, which is inco...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/5/2026
Entry Details
US Patent

TargetHistone deacetylase 6(Human)
Tenaya Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 637054BDBM637054(WO2021067859, Compound I-7B | US20250346922, Compo...)
Affinity DataIC50: 4.13nMAssay Description:The compounds disclosed herein, in particular those of Formula (II), were synthesized according to methods disclosed in WO 2021/067859, which is inco...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/5/2026
Entry Details
US Patent

TargetHistone deacetylase 6(Human)
Tenaya Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 593316BDBM593316(US11578066, Compound I-4 | N-(3-chlorophenyl)-N-((...)
Affinity DataIC50: 4.20nMAssay Description:The compounds disclosed herein, in particular those of Formula (II), were synthesized according to methods disclosed in WO 2021/067859, which is inco...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/5/2026
Entry Details
US Patent

TargetHistone deacetylase 6(Human)
Tenaya Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 593315BDBM593315(US11578066, Compound I-3 | N-(3-chlorophenyl-N-((5...)
Affinity DataIC50: 4.40nMAssay Description:The compounds disclosed herein, in particular those of Formula (II), were synthesized according to methods disclosed in WO 2021/067859, which is inco...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/5/2026
Entry Details
US Patent

TargetHistone deacetylase 6(Human)
Tenaya Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 787513BDBM787513(US20250346922, Compound II-26A)
Affinity DataIC50: 4.57nMAssay Description:The compounds disclosed herein, in particular those of Formula (II), were synthesized according to methods disclosed in WO 2021/067859, which is inco...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
3/5/2026
Entry Details
US Patent

TargetHistone deacetylase 6(Human)
Tenaya Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 593347BDBM593347(US11578066, Compound I-36 | N-(3-chlorophenyl)-N-(...)
Affinity DataIC50: 5nMAssay Description:The compounds disclosed herein, in particular those of Formula (II), were synthesized according to methods disclosed in WO 2021/067859, which is inco...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/5/2026
Entry Details
US Patent

TargetHistone deacetylase 6(Human)
Tenaya Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 787526BDBM787526(US20250346922, Compound II-36)
Affinity DataIC50: 5.22nMAssay Description:The compounds disclosed herein, in particular those of Formula (II), were synthesized according to methods disclosed in WO 2021/067859, which is inco...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
3/5/2026
Entry Details
US Patent

TargetHistone deacetylase 6(Human)
Tenaya Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 593531BDBM593531(US11578066, Compound I-223 | N-({5-[5-(difluoromet...)
Affinity DataIC50: 5.63nMAssay Description:The compounds disclosed herein, in particular those of Formula (II), were synthesized according to methods disclosed in WO 2021/067859, which is inco...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/5/2026
Entry Details
US Patent

TargetHistone deacetylase 6(Human)
Tenaya Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 593485BDBM593485(US11578066, Compound I-177 | N-[5-(difluoromethoxy...)
Affinity DataIC50: 6nMAssay Description:The compounds disclosed herein, in particular those of Formula (II), were synthesized according to methods disclosed in WO 2021/067859, which is inco...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/5/2026
Entry Details
US Patent

TargetHistone deacetylase 6(Human)
Tenaya Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 593533BDBM593533(US11578066, Compound I-225 | N-({5-[5-(difluoromet...)
Affinity DataIC50: 6.01nMAssay Description:The compounds disclosed herein, in particular those of Formula (II), were synthesized according to methods disclosed in WO 2021/067859, which is inco...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/5/2026
Entry Details
US Patent

TargetHistone deacetylase 6(Human)
Tenaya Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 637052BDBM637052(WO2021067859, Compound I-5 | US20250346922, Compou...)
Affinity DataIC50: 6.68nMAssay Description:The compounds disclosed herein, in particular those of Formula (II), were synthesized according to methods disclosed in WO 2021/067859, which is inco...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/5/2026
Entry Details
US Patent

TargetHistone deacetylase 6(Human)
Tenaya Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 593523BDBM593523(US11578066, Compound I-215 | N-({5-[5-(difluoromet...)
Affinity DataIC50: 6.75nMAssay Description:The compounds disclosed herein, in particular those of Formula (II), were synthesized according to methods disclosed in WO 2021/067859, which is inco...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/5/2026
Entry Details
US Patent

TargetHistone deacetylase 6(Human)
Tenaya Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 593465BDBM593465(US11578066, Compound I-157 | N-[5-(difluoromethoxy...)
Affinity DataIC50: 6.93nMAssay Description:The compounds disclosed herein, in particular those of Formula (II), were synthesized according to methods disclosed in WO 2021/067859, which is inco...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/5/2026
Entry Details
US Patent

TargetHistone deacetylase 6(Human)
Tenaya Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 593466BDBM593466(US11578066, Compound I-158 | N-(5-chloropyridin-3-...)
Affinity DataIC50: 7.22nMAssay Description:The compounds disclosed herein, in particular those of Formula (II), were synthesized according to methods disclosed in WO 2021/067859, which is inco...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/5/2026
Entry Details
US Patent

Displayed 1 to 50 (of 322 total ) | Next | Last >>
Jump to: